A clinical trial to compare the response of two drugs, budesonide nasal irrigation and saline nasal irrigation in patients with allergic rhinitis

A randomized control trial to compare the response to budesonide nasal irrigation versus saline irrigation in allergic rhinitis

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/04/013115

Enrollment

Registered

2018-04-09

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients diagnosed with Allergic rhinitis

Interventions

Intervention1: Budesonide nasal irrigation in allergic rhinits: 2ml of Budesonide suspension(0.5mg/2ml) is added to 120 ml of saline nasal irrigation, administered intranasally, 60ml in each nostril,

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed cases of allergic rhinitis

Exclusion criteria

Exclusion criteria: Recurrent epistaxis Systemic steroid use for indications other than allergic rhinitis Chronic eiosinophilic rhinitis Vasomotor rhinitis Active tuberculosis Pregnancy/ immunocompromised state

Design outcomes

Primary

Measure	Time frame
SNOT 22 visual analogue scale improvement by atleast 6 points visual analogue scale improvement by atleast 3 points clinical improvement in Modified Lund Kennedy score by atleast 4 pointsTimepoint: 30 days after the initial assessment.	—

Secondary

Measure	Time frame
Improvement in the quality of LifeTimepoint: 30 days after the initial assessment.	—

Countries

India

Contacts

Public ContactDrNikitha Periasamy

Manipal Accademy of Higher Education

kailesh.pujary@manipal.edu9845144015

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026